Sewart E, Turner N L, Conroy E J, Cutress R I, Skillman J, Whisker L, Thrush S, Barnes N, Holcombe C, Potter S
Population Health Sciences, Bristol Centre for Surgical Research, Bristol Medical School, Bristol, UK.
Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
BJS Open. 2021 Jan 8;5(1). doi: 10.1093/bjsopen/zraa063.
Biological and synthetic meshes may improve the outcomes of immediate implant-based breast reconstruction (IBBR) by facilitating single-stage procedures and improving cosmesis. Supporting evidence is, however, limited. The aim of this study was to explore the impact of biological and synthetic mesh on patient-reported outcomes (PROs) of IBBR 18 months after surgery.
Consecutive women undergoing immediate IBBR between February 2014 and June 2016 were recruited to the study. Demographic, operative, oncological and 3-month complication data were collected, and patients received validated BREAST-Q questionnaires at 18 months. The impact of different IBBR techniques on PROs were explored using mixed-effects regression models adjusted for clinically relevant confounders, and including a random effect to account for clustering by centre.
A total of 1470 participants consented to receive the questionnaire and 891 completed it. Of these, 67 women underwent two-stage submuscular reconstructions. Some 764 patients had a submuscular reconstruction with biological mesh (495 women), synthetic mesh (95) or dermal sling (174). Fourteen patients had a prepectoral reconstruction. Compared with two-stage submuscular reconstructions, no significant differences in PROs were seen in biological or synthetic mesh-assisted or dermal sling procedures. However, patients undergoing prepectoral IBBR reported better satisfaction with breasts (adjusted mean difference +6.63, 95 per cent c.i. 1.65 to11.61; P = 0.009). PROs were similar to those in the National Mastectomy and Breast Reconstruction Audit 2008-2009 cohort, which included two-stage submuscular procedures only.
This study found no difference in PROs of subpectoral IBBR with or without biological or synthetic mesh, but provides early data to suggest improved satisfaction with breasts following prepectoral reconstruction. Robust evaluation is required before this approach can be adopted as standard practice.
生物和合成网片可通过促进一期手术并改善美容效果,来提高即刻植入式乳房重建(IBBR)的疗效。然而,支持证据有限。本研究的目的是探讨生物和合成网片对IBBR术后18个月患者报告结局(PROs)的影响。
纳入2014年2月至2016年6月期间连续接受即刻IBBR的女性。收集人口统计学、手术、肿瘤学和3个月并发症数据,患者在18个月时接受经过验证的BREAST-Q问卷。使用针对临床相关混杂因素进行调整的混合效应回归模型,探讨不同IBBR技术对PROs的影响,并纳入随机效应以考虑中心聚类。
共有1470名参与者同意接受问卷,891人完成问卷。其中,67名女性接受了两期胸肌下重建。约764例患者进行了胸肌下重建,使用生物网片(495名女性)、合成网片(95名)或真皮吊带(174名)。14例患者进行了胸大肌前重建。与两期胸肌下重建相比,在生物或合成网片辅助或真皮吊带手术中,PROs没有显著差异。然而,接受胸大肌前IBBR的患者对乳房的满意度更高(调整后平均差异+6.63,95%置信区间1.65至11.61;P = 0.009)。PROs与2008 - 2009年全国乳房切除术和乳房重建审计队列相似,该队列仅包括两期胸肌下手术。
本研究发现,有或没有生物或合成网片的胸肌下IBBR的PROs没有差异,但提供了早期数据表明胸大肌前重建后对乳房的满意度有所提高。在将这种方法作为标准做法采用之前,需要进行有力的评估。